Census Bureau Estimate: World Population Is 7.6 Billion, U.S. 330.2 Million On New Years Day 2020

United States Census Bureau January 1 2020 Estimate of World and U.S. Populations

DEC. 30, 2019 — As the nation prepares to ring in the new year, the U.S. Census Bureau projects the U.S. population will be 330,222,422 on Jan. 1, 2020. This represents an increase of 1,991,085, or 0.61%, from New Year’s Day 2019. Since Census Day (April 1) 2010, the population has grown by 21,476,884 or 6.96%.

In January 2020, the United States is expected to experience one birth every eight seconds and one death every 11 seconds. Meanwhile, net international migration is expected to add one person to the U.S. population every 34 seconds. The combination of births, deaths and net international migration will increase the U.S. population by one person every 19 seconds.

The projected world population on Jan. 1, 2020, is 7,621,018,958, an increase of 77,684,873, or 1.03%, from New Year’s Day 2019. During January 2020, 4.3 births and 1.9 deaths are expected worldwide every second.

The Census Bureau’s U.S. and World Population Clock simulates real-time growth of the United States and world populations at <www.census.gov/popclock>.

Website

Dementia: Cognitive Loss Is Greatest At “Slightest Level Of Hearing Loss”

From a New York Times online article:

Hearing Loss…the researchers demonstrated that the biggest drop in cognitive ability occurs at the slightest level of hearing loss — a decline from zero to the “normal” level of 25 decibels, with smaller cognitive losses occurring when hearing deficits rise from 25 to 50 decibels.

Hearing loss is now known to be the largest modifiable risk factor for developing dementia, exceeding that of smoking, high blood pressure, lack of exercise and social isolation, according to an international analysis published in The Lancet in 2017.

the new findings on cognitive losses linked to subclinical hearing loss, gleaned from among 6,451 people age 50 or older, suggest that any degree of hearing loss can take a toll.

To read more

Interviews: 63-Year Old Guido Van Rossum, Python Programming Language Creator (Oxford Union)

Van Rossum is a Dutch programmer and the author of the programming language Python. Python was first released in 1991 and is now one of the world’s most popular coding languages. Van Rossum was the language’s Benevolent Dictator for Life until 2018, and now sits on the Python Steering Council. He has also developed software for Google, and currently works at Dropbox.

ABOUT THE OXFORD UNION SOCIETY (OUS): The Oxford Union is the world’s most prestigious debating society, with an unparalleled reputation for bringing international guests and speakers to Oxford. Since 1823, the Union has been promoting debate and discussion not just in Oxford University, but across the globe.

Website

Self-Checkout Tech: “Trigo Vision” Uses 3-D Imaging + AI For “Scan-And-Go” Shopping (Video)

Trigo’s network of ceiling-mounted cameras sees what no other system can see. We create a 3D image of the shop-floor environment, and map the movement of every object as consumers shop.

Trigo Vision Technology Computer Vision + AI Retail Store

Our proprietary algorithms and neural networks enable a frictionless shopping experience, where consumers can enter the store, pick and leave.

Website

New Aerial Travel Videos: “Christmas Market” In Erfurt, Germany (4K)

Filmed, Edited and Directed by: Dennis Schmelz

I’ve been waiting for these conditions since more than six years. A few days ago it was finally possible to capture my hometown Erfurt with fog during the golden hour, for a few minutes the whole town looked like a fairytale world. Lay back and enjoy this short edit of the beautiful Christmas market and the old town of Erfurt.

Music by:  Patrick Hawes & Grace Davidson (“Quiet Waters”)

Website

2020 Exhibitions: “Marie Cuttoli – The Modern Thread From Miró To Man Ray” (Barnes Foundation)

BF logo 01

In 1930s Paris, leading modern artists experimented with tapestry design, thanks to pioneering entrepreneur Marie Cuttoli (1879–1973). Cuttoli lived between Algeria Marie Cuttoli Modern Tapestry from Picasso to Le Corbusier bookand Paris and collected work by artists such as Pablo Picasso, Joan Miró, and Georges Braque.

This exhibition traces her career, from her early work in fashion and interiors to her revival of the French tapestry industry. She commissioned the most celebrated artists of her time—Rouault, Léger, Picasso, Braque, Le Corbusier, Man Ray, and Miró, among others—to create designs for the historic tapestry workshops in Aubusson. By uniting these important paintings and drawings with the resulting tapestry, this exhibition shows their true purpose, revealing modernism’s profound dialogue with the decorative arts.

Read more

Healthcare: “10 Drugs And Medical Devices Approved By FDA In Dec. 2019 (BHR)

From a Becker’s Hospital Review (BHR) online release article:

10 drugs and medical devices approved by the FDA since Dec. 6:

  1. Enhertu is Japanese drugmaker Daiichi Sankyo’s drug designed to treat HER2-positive breast cancer.
  2. Padcev is Astellas Pharma’s drug designed to target specific cancer cells to treat urothelial cancers.
  3. Control-IQ Technology controller is Tandem Diabetes Care’s insulin device, designed to help diabetes patients tailor their treatments to their individual needs.
  4. Vascepa is Amarin Pharmaceuticals’ drug, a fish oil-derived pill designed to treatVascepa benefits cardiovascular events.
  5. EXALT Model D is Boston Scientific’s device, the first fully disposable duodenoscope, designed to reduce the risk of infections in patients treated with the device.
  6. Vyondys 53 is Sarepta Therapeutics’ drug designed to treat Duchenne muscular dystrophy, which the FDA had previously rejected.
  7. GSP Neonatal Creatine Kinase-MM kit is PerkinElmer’s device, used to detect Duchenne Muscular Dystrophy in newborns.
  8. Unidose liquid system is AptarGroup’s device that uses a nasal spray to treat seizures. It is the first and only nasal treatment for patients with epilepsy.
  9. Avsola is Amgen’s drug, a biosimilar of Johnson & Johnson’s Remicade. It is designed to treat rheumatoid arthritis, Crohn’s disease, plaque psoriasis, psoriatic arthritis and ankylosing spondylitis.
  10. cobas vivoDx is Roche Molecular Systems’ device, designed to diagnose MRSA hours faster than traditional tests.

Becker's Hosptial Review logo

To read article at Becker’s Hospital Review